Slater Lee-Anne, Soufan Cathy, Holt Michael, Chong Winston
Interventional Neuroradiology Unit, Department of Diagnostic Imaging Monash Health, Melbourne, Australia.
Interventional Neuroradiology Unit, Department of Diagnostic Imaging Monash Health, Melbourne, Australia
Interv Neuroradiol. 2015 Feb;21(1):12-8. doi: 10.1177/1591019915576433.
Alterations in aneurysm size and mass effect can result in alleviation or aggravation of symptoms. We assessed the effects of flow diversion with SILK stents on aneurysm sac size and associated factors. A retrospective evaluation of 14 aneurysms treated with SILK stents alone with MRI follow-up was performed. Aneurysm sac size was measured using the sequence best demonstrating the sac. Aneurysm characteristics and flow-related enhancement on time of flight images were documented. Clinical histories were reviewed for evolution of symptoms. Complete collapse of the aneurysm sac was demonstrated at three and 18 months in 2/14 aneurysms. Increase in size was observed in 2/14 aneurysms with associated persistent flow on time of flight MRA. Blister formation with aggravation of symptoms was observed in one aneurysm, and subsequent decrease in size occurred after treatment with a second SILK. The other aneurysm which increased in size initially continued to enlarge asymptomatically despite retreatment with a second SILK, however at 24 months thrombosis of the sac and decrease in size was observed. The remaining 10/14 aneurysms decreased in size. Nine had corresponding MRA occlusion and the tenth demonstrated decreased but persistent flow on the time of flight MRA. No aneurysm with MRA occlusion increased in size. Decrease in sac size was associated with MRA occlusion in our study. Persistence of flow and blistering were associated with increased sac size. As previously demonstrated flow diversion may be effective in the treatment of large aneurysms presenting with mass effect, however rates of sac obliteration in this small series were not as high as previously reported.
动脉瘤大小和占位效应的改变可导致症状减轻或加重。我们评估了使用SILK支架进行血流导向对动脉瘤瘤腔大小及相关因素的影响。对14例仅接受SILK支架治疗且有MRI随访结果的动脉瘤进行了回顾性评估。使用最能清晰显示瘤腔的序列测量动脉瘤瘤腔大小。记录动脉瘤特征及时间飞跃图像上与血流相关的强化情况。回顾临床病史以了解症状演变。14例动脉瘤中有2例在3个月和18个月时瘤腔完全闭塞。14例动脉瘤中有2例瘤腔增大,时间飞跃磁共振血管造影(MRA)显示有持续血流。1例动脉瘤出现水泡形成且症状加重,在置入第二个SILK支架治疗后瘤腔大小随后减小。另1例最初增大的动脉瘤尽管再次置入第二个SILK支架仍无症状性继续增大,但在24个月时瘤腔血栓形成且大小减小。其余10/14例动脉瘤大小减小。9例MRA显示闭塞,第10例时间飞跃MRA显示血流减少但仍持续存在。MRA显示闭塞的动脉瘤无增大情况。在我们的研究中,瘤腔大小减小与MRA闭塞相关。血流持续存在和水泡形成与瘤腔增大相关。如先前所示,血流导向可能对有占位效应的大型动脉瘤治疗有效,然而在这个小系列研究中瘤腔闭塞率不如先前报道的高。